Efficacy of Eprex in the treatment of anemia in predialysis patients with chronic renal failure
- Author:
Dung Thi Kim Dinh
- Publication Type:Journal Article
- Keywords:
chronic renal failure
- MeSH:
Kidney Failure, Chronic;
Epoetin Alfa
- From:Journal of Vietnamese Medicine
2001;258(4):80-86
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Eprex used to treat anemia and improves quality of life, assessment and exercise capacity in predialysis patients. There are two groups of predialysis patients with Hemoglobin <100 g/dl, follow up 5 months in our study: group A (n=17; Eprex- treated predialysis patients) for the treatment by Eprex with 2000 UI x 2 time/week x 2 months, and continuous 2000 UI/week x 3 months; group B non anemia treatment (n=11 non Eprex - treated predialysis patients). The results after 5 months follow up: group A receiving Eprex had higher RBC, Hb and Ht levels than those non receiving Eprex (group B) with P<0.001. The Eprex - treated predialysis patients in group A for a duration of 5 months and observed no accelerated decline in renal function compared with non - Eprex treated predialysis patients, treatment of anemia might improved energy level and physical function.
